These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 6354745)

  • 1. [Theory of organotropism of roentgen contrast media].
    Sergeev PV; Shimanovskiĭ NL; Belykh AG
    Farmakol Toksikol; 1983; 46(5):61-72. PubMed ID: 6354745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacokinetics and plasma albumen binding of iotroxic acid (Biliscopin), iodoxic acid (Endomirabil) and ioglycamine (Biligram) (author's transl)].
    Taenzer V; Speck U; Wolf R
    Rofo; 1977 Mar; 126(3):262-7. PubMed ID: 139346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Reaction between x-ray contrast media and dyes and hepatocyte plasma membranes].
    Sergeev PV; Belykh AG
    Farmakol Toksikol; 1981; 44(2):195-200. PubMed ID: 7274428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein binding of metrizamide and the effect on various enzymes.
    Salvesen S; Frey K
    Acta Radiol Suppl; 1973; 335():247-52. PubMed ID: 4534560
    [No Abstract]   [Full Text] [Related]  

  • 5. [The mechanisms of the interaction of contrast media with serum albumin and gamma-globulin studied by means of fluorescence extinction and equilibrium dialysis].
    Shabunin IV; Panov VO; Kalinina AA; Shimanovskiĭ NL; Sergeev PV
    Eksp Klin Farmakol; 1996; 59(5):43-6. PubMed ID: 9026210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Distribution and excretion of iodamide-380 determined by roentgen fluorescence analysis].
    Zajcik VE; Amosov IS; Frolova EI; Jakovlev VJa
    Radiol Diagn (Berl); 1983; 24(3):429-34. PubMed ID: 6611913
    [No Abstract]   [Full Text] [Related]  

  • 7. The extraordinary ligand binding properties of human serum albumin.
    Fasano M; Curry S; Terreno E; Galliano M; Fanali G; Narciso P; Notari S; Ascenzi P
    IUBMB Life; 2005 Dec; 57(12):787-96. PubMed ID: 16393781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Albumin binding of the hepatotropic contrast medium Biligrafin].
    Pfab R
    Rontgenblatter; 1973 Jun; 26(6):282-6. PubMed ID: 4135062
    [No Abstract]   [Full Text] [Related]  

  • 9. [Influence of serum-binding capacity on the contrast media in the cholangiocystogram].
    Kölling K; Schoen D
    Fortschr Geb Rontgenstr Nuklearmed; 1970 Sep; 113(3):372-5. PubMed ID: 5533871
    [No Abstract]   [Full Text] [Related]  

  • 10. [Results and conclusions from metabolic studies of I 131 -falignost].
    Barke R; Hieckel HG
    Radiol Diagn (Berl); 1972; 13(6):805-15. PubMed ID: 4657544
    [No Abstract]   [Full Text] [Related]  

  • 11. [Biotransformation of iomeglamic acid (Falignost)].
    Bornschein I; Borchert HH; Pfeifer S
    Pharmazie; 1974; 29(10-11):730-1. PubMed ID: 4438422
    [No Abstract]   [Full Text] [Related]  

  • 12. The nonselective adenosine antagonist theophylline does prevent renal dysfunction induced by radiographic contrast agents.
    Kolonko A; Wiecek A; Kokot F
    J Nephrol; 1998; 11(3):151-6. PubMed ID: 9650124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms for the hepatic uptake of magnetic resonance imaging contrast agents.
    Pascolo L; Cupelli F; Anelli PL; Lorusso V; Visigalli M; Uggeri F; Tiribelli C
    Biochem Biophys Res Commun; 1999 Apr; 257(3):746-52. PubMed ID: 10208854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting exofacial protein thiols with Gd(III) complexes. An efficient procedure for MRI cell labelling.
    Digilio G; Catanzaro V; Fedeli F; Gianolio E; Menchise V; Napolitano R; Gringeri C; Aime S
    Chem Commun (Camb); 2009 Feb; (8):893-5. PubMed ID: 19214307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast-protein interactions.
    Lasser EC; Lang JH
    Invest Radiol; 1970; 5(6):446-57. PubMed ID: 5501849
    [No Abstract]   [Full Text] [Related]  

  • 16. Fatty acid interactions with proteins: what X-ray crystal and NMR solution structures tell us.
    Hamilton JA
    Prog Lipid Res; 2004 May; 43(3):177-99. PubMed ID: 15003394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies of plasma membrane fatty acid-binding protein and other lipid-binding proteins in human skeletal muscle.
    Roepstorff C; Helge JW; Vistisen B; Kiens B
    Proc Nutr Soc; 2004 May; 63(2):239-44. PubMed ID: 15294037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization and regulation of SR-BI in membrane rafts of HepG2 cells.
    Rhainds D; Bourgeois P; Bourret G; Huard K; Falstrault L; Brissette L
    J Cell Sci; 2004 Jul; 117(Pt 15):3095-105. PubMed ID: 15226391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NMR structural studies of the supramolecular adducts between a liver cytosolic bile acid binding protein and gadolinium(III)-chelates bearing bile acids residues: molecular determinants of the binding of a hepatospecific magnetic resonance imaging contrast agent.
    Assfalg M; Gianolio E; Zanzoni S; Tomaselli S; Russo VL; Cabella C; Ragona L; Aime S; Molinari H
    J Med Chem; 2007 Nov; 50(22):5257-68. PubMed ID: 17915850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Biotransformation of iodoxanic acid in humans].
    Pitrè D; Fumagalli L
    Radiol Med; 1970 Sep; 56(9):836-43. PubMed ID: 5210612
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.